Matches in Wikidata for { <http://www.wikidata.org/entity/Q104259813> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q104259813 description "2020 թվականի դեկտեմբերի 10-ին հրատարակված գիտական հոդված" @default.
- Q104259813 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 10ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104259813 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q104259813 description "scientific article published on 10 December 2020" @default.
- Q104259813 description "wetenschappelijk artikel" @default.
- Q104259813 description "наукова стаття, опублікована 10 грудня 2020" @default.
- Q104259813 name "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy" @default.
- Q104259813 name "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy" @default.
- Q104259813 name "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy" @default.
- Q104259813 type Item @default.
- Q104259813 label "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy" @default.
- Q104259813 label "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy" @default.
- Q104259813 label "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy" @default.
- Q104259813 prefLabel "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy" @default.
- Q104259813 prefLabel "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy" @default.
- Q104259813 prefLabel "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy" @default.
- Q104259813 P1433 Q104259813-7BDACCE8-6FA9-4CF5-9246-3F60D9EF10FD @default.
- Q104259813 P1476 Q104259813-23167B08-7339-42DB-8739-179B0DA506D9 @default.
- Q104259813 P2093 Q104259813-0A887624-5E66-4305-9918-50D02EA633C4 @default.
- Q104259813 P2093 Q104259813-11CDFCC6-FFD4-4E5B-BFBB-ECAD598E0CDB @default.
- Q104259813 P2093 Q104259813-23F7AD76-693F-4BF8-967A-6DC0067DB062 @default.
- Q104259813 P2093 Q104259813-2A2F56D5-FF17-4507-B7F4-65857361C59F @default.
- Q104259813 P2093 Q104259813-3A8CC1C1-A52F-4F75-B59A-92FA5BAA60CB @default.
- Q104259813 P2093 Q104259813-662B8A23-6248-463E-BA3D-321B0983A080 @default.
- Q104259813 P2093 Q104259813-C8F855D3-8AC1-4767-A386-5FD2D823AF05 @default.
- Q104259813 P2860 Q104259813-DF5C9107-567D-4F71-8296-052C7C93D35A @default.
- Q104259813 P304 Q104259813-E81B0D0A-3FB1-4E05-B300-71AEA23CFD93 @default.
- Q104259813 P31 Q104259813-4D25AEEF-EDA4-4085-8D51-D6B5D3012E0E @default.
- Q104259813 P356 Q104259813-9571BF98-F711-48D3-9A71-E568E010DB94 @default.
- Q104259813 P50 Q104259813-F048D7AA-025C-468B-97A1-BB78D49B6C69 @default.
- Q104259813 P577 Q104259813-8F43CFC2-62D1-4C52-8BB8-3552D7BAA0A7 @default.
- Q104259813 P698 Q104259813-9DC9726C-798A-4193-B67F-EC139C70C1BD @default.
- Q104259813 P921 Q104259813-61C2D064-F529-4FB3-9178-608DE159CFF1 @default.
- Q104259813 P921 Q104259813-813E7FB6-A313-483D-BD95-BB5559B56944 @default.
- Q104259813 P921 Q104259813-B9459F74-9669-46C1-8F3D-56552D64E00F @default.
- Q104259813 P356 10428194.2020.1856833 @default.
- Q104259813 P698 33300380 @default.
- Q104259813 P1433 Q6534493 @default.
- Q104259813 P1476 "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy" @default.
- Q104259813 P2093 "Funda Aydin" @default.
- Q104259813 P2093 "Hasan Sözel" @default.
- Q104259813 P2093 "Levent Undar" @default.
- Q104259813 P2093 "Orhan Kemal Yücel" @default.
- Q104259813 P2093 "Ozan Salim" @default.
- Q104259813 P2093 "Yıldız Kılar Sözel" @default.
- Q104259813 P2093 "Ünal Ataş" @default.
- Q104259813 P2860 Q27860529 @default.
- Q104259813 P304 "1-9" @default.
- Q104259813 P31 Q13442814 @default.
- Q104259813 P356 "10.1080/10428194.2020.1856833" @default.
- Q104259813 P50 Q91309173 @default.
- Q104259813 P577 "2020-12-10T00:00:00Z" @default.
- Q104259813 P698 "33300380" @default.
- Q104259813 P921 Q1787939 @default.
- Q104259813 P921 Q2626074 @default.
- Q104259813 P921 Q4833719 @default.